menu
    • menu

    Company profile for AbVacc

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AbVacc, Inc. is a biotechnology company pioneering structure-guided vaccine and therapeutic development for emerging infectious diseases. With a strong pipeline targeting bacterial and viral infections, AbVacc focuses on S. aureus virulence factors, including its IBT-V02 vaccine, set for clinical trials in 2024. The company also develops potent antibodies against Ebola, Marburg, and Nipah viruses. Based in Rockville, Maryland,...
    AbVacc, Inc. is a biotechnology company pioneering structure-guided vaccine and therapeutic development for emerging infectious diseases. With a strong pipeline targeting bacterial and viral infections, AbVacc focuses on S. aureus virulence factors, including its IBT-V02 vaccine, set for clinical trials in 2024. The company also develops potent antibodies against Ebola, Marburg, and Nipah viruses. Based in Rockville, Maryland, AbVacc collaborates with U.S. government agencies, biotech firms, and academic institutions to advance innovative treatments for global health threats.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AbVaccUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4 Research Ct, Suite 310 Rockville, MD 20850
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.abvacc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS Asia

    IMCAS Asia

    Not Confirmed

    envelop Contact Supplier

    IMCAS Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Blue Water Vaccines Announces Partnership with AbVacc
    Blue Water Vaccines Announces Partnership with AbVacc

    01 Feb 2023

    // PRESS RELEASE

    https://www.abvacc.com/news-detail-4.html

    PRESS RELEASE
    01 Feb 2023
    Share Share
    Blue Water Vaccines Announces Partnership with AbVacc for Vaccine Candidates
    Blue Water Vaccines Announces Partnership with AbVacc for Vaccine Candidates

    01 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/01/2599613/0/en/Blue-Water-Vaccines-Announces-Partnership-with-AbVacc-for-Joint-Development-of-Novel-Monkeypox-and-Marburg-Vaccine-Candidates.html

    GLOBENEWSWIRE
    01 Feb 2023
    Share Share
    Integrated BioTherapeutic Spin-off Renamed AbVacc Inc.
    Integrated BioTherapeutic Spin-off Renamed AbVacc Inc.

    30 Jan 2023

    // PRESS RELEASE

    https://www.abvacc.com/news-details.html

    PRESS RELEASE
    30 Jan 2023
    Share Share
    Integrated & Integral Molecular Partner on Ebolavirus Vaccines
    Integrated & Integral Molecular Partner on Ebolavirus Vaccines

    01 Nov 2021

    // PRESS RELEASE

    https://www.abvacc.com/news-details-1.html

    PRESS RELEASE
    01 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search